Novavax Names Jeffrey Church Chief Financial Officer
Novavax, Inc. said that Jeffrey Church has been appointed Vice President, Chief Financial Officer and Treasurer, effective September 5, 2006. Mr. Church joins Novavax from GenVec, Inc., where he served as CFO, Treasurer and Corporate Secretary since 1988. During his tenure at GenVec, Mr. Church raised approximately $150 million in debt and equity financing.
A certified public accountant, Mr. Church was an Executive Vice President, CFO and Director of Biospherics Inc., now known as Spherix, where he directed a team of 250 professionals in sales and marketing, technical services and financial functions. Prior to Biospherics, Mr. Church served as Senior Vice President and CFO of the device concern Meridian Medical Technologies Inc. Mr. Church helped in transforming Meridian from an unprofitable defense contractor to a profitable medical device company that, subsequently, was acquired by King Pharmaceuticals for $247 million.
A summa cum laude graduate of the University of Maryland, Mr. Church began his career as an audit manager in the Baltimore, Maryland, office of Price Waterhouse.
Other news from the department people

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.